OVATION Receives Fast Track Designation For Sabril(R) To Treat Cocaine And Methamphetamine Dependence
OVATION Pharmaceuticals, Inc. announced that Sabril(R) (vigabatrin) has received Fast Track designation from the U.S. Food and Drug Administration (FDA), potentially expediting development of this novel compound that is being evaluated for the treatment of cocaine and methamphetamine dependence.
More: continued here